exeq bioforum 2012 presentation
DESCRIPTION
Exeq presentation of funding opportunities for the biotechnology sectorTRANSCRIPT
![Page 1: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/1.jpg)
Public funding opportunities for R&D
and innovation projects
Jan Kaczmarek, CSO, Partner – EXEQ
![Page 2: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/2.jpg)
2Public funding for R&D&I
about us• grant consultancy• specilized in R&D and innovation programmes• 7 years in business• team of 10 consultants• domain experts (computer science,
telecommunications, biotech) from recognised R&D institutes
• ~20 projects annually• success rate: ~3 x average retention rate
![Page 3: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/3.jpg)
3Public funding for R&D&I
about me• Co-funder of EXEQ• R&D project manager, proposal writer, consortia
matchmaker (since 2004)• (co)authored over 50 proposals• ~ 10K working hours• Economics and IT background• Project evaluator (incl. 7th Framework Programme)
![Page 4: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/4.jpg)
4Public funding for R&D&I
customers
![Page 5: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/5.jpg)
5Public funding for R&D&I
EU-level programmes
![Page 6: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/6.jpg)
6Public funding for R&D&I
programmes in Poland
Technological Loans
R&D project for companies
1.4 3.3.2 5.4.1 6.1
8.1 8.2
2.1.1 6.1
![Page 7: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/7.jpg)
7Public funding for R&D&I
agenda• introduction• overview of funding opportunities• profiles of selected programmes• call calendar excerpt
• Q&A
![Page 8: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/8.jpg)
8Public funding for R&D&I
motto
„People say you have to rob your first 1 million, I got mine from a public grant”
- Mateusz Flis, founder of Ives System
![Page 9: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/9.jpg)
9Public funding for R&D&I
overview• 7th Framework Programme --> Horizon 2020• Eureka• Eurostars• ERASME• EEA Grants• Israeli Industrial bilateral R&D Cooperation
Framework
![Page 10: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/10.jpg)
10
Public funding for R&D&I
7th Framework Programme
Planned for the years 2007-2013
--> Horizon 2020 (in 587 days)
Total budget of € 50 billion
•based on calls for proposals •peer reviewed•highly competitive•medium to large cross-EU consortia•considerable budgets (EUR ~2-20M)
![Page 11: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/11.jpg)
11
Public funding for R&D&I
who can apply?
open to a wide range of organisations, including:
• research groups at universities or research institutes
• small or medium-sized enterprises (SMEs)
• public or governmental administration (local, regional or national)
• international organisations
• civil society organisations
from:
EU member countries & associate countries (EEA, candidate countries, Israel, Switzerland)
![Page 12: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/12.jpg)
12
Public funding for R&D&I
FP Structure5 major building blocks: • Ideas• People• Capacities• Nuclear Research• Cooperation (the core of FP7, representing two thirds
of the overall budget)
Ten thematic areas including: • HEALTH• FOOD, AGRICULTURE AND FISHERIES,
BIOTECHNOLOGY
![Page 13: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/13.jpg)
13
Public funding for R&D&I
basic FP rules
Participation Duration Max budget Funding rate
Average: 5 - 16 36 monthsOn average: EU contribution €2M
R&D activities up to 75%Demonstration 50%Other up to 100%
![Page 14: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/14.jpg)
14
Public funding for R&D&I
calls• Health - 20 closed calls• Food, Agriculture and Fisheries, and Biotechnology –
21 closed calls
• Work Programmes for 2013 expected in mid-July 2012
http://ec.europa.eu/research/participants/portal/page/cooperation
• Orientation paper now online!, via the above address
![Page 15: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/15.jpg)
15
Public funding for R&D&I
topics in the orientation paper
BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES FOR HUMAN HEALTH
• 1.1 High-throughput research• 1.2 Detection, diagnosis and monitoring• 1.3 Suitability, safety, efficacy of therapies• 1.4 Innovative therapeutic approaches and interventionsTRANSLATING RESEARCH FOR HUMAN HEALTH• 2.1 Integrating biological data and processes: large-scale data
gathering, systems biology• 2.2 Research on the brain and related diseases, human development
and ageing• 2.3 Translational research in major infectious diseases: to confront
major threats to public health• 2.3.1 Anti-microbial drug resistance
2.3.2 HIV/AIDS, malaria and tuberculosis2.3.3 Potentially new and re-emerging epidemics2.3.4 Neglected infectious diseases
![Page 16: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/16.jpg)
16
Public funding for R&D&I
topics in the orientation paper
• 2.4 Translational research in other major diseases2.4.1 Cancer2.4.2 Cardiovascular diseases2.4.3 Diabetes and obesity2.4.4 Rare diseases2.4.5 Other chronic diseases
• 3.1 Translating the results of clinical research outcome into clinical practice
• 3.2 Quality, efficiency and solidarity of healthcare systems
• 3.3 Health promotion and prevention
![Page 17: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/17.jpg)
17
Public funding for R&D&I
EUREKA
• International network of 40 partners
• 200 projects yearly
• Any technological area
MAIN RULES:
• At least 2 partners from 2 different member countries
• Funded under national funding schemes
• Market driven
![Page 18: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/18.jpg)
18
Public funding for R&D&I
EUREKAFunding schemes:
(1) individual projects
Open call (around 490 running projects)
(2) umbrellas
Thematic networks
EUROAGRI FOOD CHAIN (2009-2013)
(3) Clusters
Long-term, strategically significant industry initiatives
ACQUEAU (2010-2015)
(4) EUROSTARS
![Page 19: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/19.jpg)
19
Public funding for R&D&I
EUREKA
Participation Duration Max budget Funding rate
At least 2 partners from 2 different member countries
Not specified € 1,6 Mon average
According to national rules
![Page 20: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/20.jpg)
20
Public funding for R&D&I
EUROSTARS
• Funding industrial research carried out by SME’s
• €400M of budget
• 2 calls of proposals yearly
• Any technological area
• New product, process or service
• Market perspective
• Leader: R&D-performing SME
• At least 50% of R&D work done by SMEs
• Funded under national schemes
![Page 21: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/21.jpg)
21
Public funding for R&D&I
EUROSTARS
Participation Duration Budget Funding rate Upcoming call
At least 2 partners from 2 different member countries
Up to 36 months
Not specified According to national rules
Autumn 2012
On average:3 to 4 partners
On average:29 months
On average:€1,4 M
-- --
![Page 22: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/22.jpg)
22
Public funding for R&D&I
EUROSTARSExamples:
Eurostars E!4258 ISTAR
Injection System for Transderm Administration of dRugs
Budget: 3580000 €
Led by: CROSSJECT Medical Technology (France)
E! 4731 Arrayvolution
A revolution in flexible cost-effective DNA and high density microarray production
Budget: 1443500 €
Led by: FlexGen (The Netherlands)
![Page 23: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/23.jpg)
23
Public funding for R&D&I
EEA Grants• „EEA structural funds”• Key areas of support : environmental protection, climate
change, research and scholarships, civil society, health and children, gender equality, justice and cultural heritage.
• 2009-14: €1.79 billion (Norway: 97%)
• Available for NGOs, research and academic institutions, and the public and private sectors in the 12 newest EU member states, Greece, Portugal and Spain.
• The funding backs programmes and projects in priority areas agreed with each country.
![Page 24: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/24.jpg)
24
Public funding for R&D&I
EEA Grants
http://www.eeagrants.org
![Page 25: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/25.jpg)
25
Public funding for R&D&I
Israeli bilateral coop.Sellected calls:Czech Republic-Israel Industrial R&D Cooperation Framework (Dec2012?)Russia-Israel Call for Proposals (10 Sept)
Countries involved:Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Lithuania, Poland, Romania, Russia, Spain, Sweden, Switzerland, Turkey, UK
![Page 26: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/26.jpg)
26
Public funding for R&D&I
calls calendar• 7th Framework Programme --> 2013 (to be published
mid-July)• Eureka - ongoing• Eurostars – Autumn 2012• ERASME – 28th September 2012• Celtic – 15th October 2012• Israeli Industrial bilateral R&D Cooperation
Framework – September with Russia, Poland and Czech Republic
If you want to stay tuned subscribe to our newsletter at: www.exeq.eu
![Page 27: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/27.jpg)
27
Public funding for R&D&I
food 4 thought• keep focus on your idea• be market oriented• team up with academics• build up your research project portfolio• money is not all you can get• submit often, never give up
![Page 28: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/28.jpg)
28
Public funding for R&D&I
questions?
![Page 29: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/29.jpg)
29
Public funding for R&D&I
how we can help…• Research concept• State of the art analysis• Market research• Concept adaptation• Program search• Project parter serach• Standard consortium agreement• Project budgeting• Project plan and tasks• Project application form filling out and submission
![Page 30: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/30.jpg)
30
Public funding for R&D&I
…• Project financial reporting• Project merit reporting• Project merit audit• Project formal audit• Project reporting training• R&D projects funding possibilities training• Project application preparation training
![Page 31: Exeq BioForum 2012 presentation](https://reader035.vdocuments.mx/reader035/viewer/2022062705/5567f902d8b42aaf768b4f33/html5/thumbnails/31.jpg)
31
Public funding for R&D&I
contact me!Exeq (a brand of Disruptive Concepts Sp. z o.o.)ul. Willowa 2 lok. 1, 00-790 Warsaw, Poland
E-mail: [email protected]
@exeq_eu
facebook.com/EXEQ.EU
linkedin.com/companies/exeq
Find us on: www.exeq.eu